What is it about?
Our report discuss the metabolic changes like dyslipidemia and increase blood glucose in patients with second line HAART
Featured Image
Why is it important?
Increase cardiovascular risk can be associated with second line HAART patient with significant dyslipidemia and diabetes mellitus. Timely identification and change of therapy is vital to prevent morbidity and mortality
Read the Original
This page is a summary of: Metabolic changes in the patients on second-line highly active antiretroviral therapy (HAART): A prospective cohort study from north India, Journal of Family Medicine and Primary Care, January 2020, Medknow,
DOI: 10.4103/jfmpc.jfmpc_1208_19.
You can read the full text:
Contributors
The following have contributed to this page
